OSENI - alogliptin and pioglitazone
Navigation: NDC > Supplier starting with: T > TAKEDA PHARMACEUTICALS AMERICA, INC.| Field | Value |
|---|---|
| NDC Code: | 64764-123 |
| Proprietary Name: | OSENI |
| Suffix: | |
| Non-Proprietary Name: | alogliptin and pioglitazone |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 25-01-2013 |
| Category Name: | NDA |
| Application Number: | NDA022426 |
| Labeler: | TAKEDA PHARMACEUTICALS AMERICA, INC. |
| Substance Name: | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
| Active Numerator Strength: | 12.5; 30 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |
| DEA Schedule: |